Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 1982; Volume 22,Issue 3
  • You have access
    Quantum chemical analysis of structure-activity relationships in nonsteroidal anti-inflammatory drugs.
    E L Mehler, J Habicht and K Brune
    Molecular Pharmacology November 1982, 22 (3) 525-528;
  • You have access
    Initiation of in vitro lipid peroxidation by N-hydroxynorcocaine and norcocaine nitroxide.
    G M Rosen, M W Kloss and E J Rauckman
    Molecular Pharmacology November 1982, 22 (3) 529-531;
  • You have access
    Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
    M D Snavely and P A Insel
    Molecular Pharmacology November 1982, 22 (3) 532-546;
  • You have access
    Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils.
    C Gespach, F Saal, H Cost and J P Abita
    Molecular Pharmacology November 1982, 22 (3) 547-553;
  • You have access
    Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
    M J Marks and A C Collins
    Molecular Pharmacology November 1982, 22 (3) 554-564;
  • You have access
    Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
    J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque
    Molecular Pharmacology November 1982, 22 (3) 565-573;
  • You have access
    Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
    D E Macfarlane and D C Stump
    Molecular Pharmacology November 1982, 22 (3) 574-579;
  • You have access
    Bidirectional collision coupling in the regulation of the adenylate cyclase. The allozyme hypothesis for receptor function.
    D E Macfarlane
    Molecular Pharmacology November 1982, 22 (3) 580-588;
  • You have access
    Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
    E A Woodcock and C I Johnston
    Molecular Pharmacology November 1982, 22 (3) 589-594;
  • You have access
    Selective effects of an essential sulfhydryl group on the activation of dopamine- and guanine nucleotide-sensitive adenylate cyclase.
    E T Suen, P C Kwan and Y C Clement-Cormier
    Molecular Pharmacology November 1982, 22 (3) 595-601;
  • You have access
    Pharmacological characterization of histamine receptors mediating cyclic AMP accumulation in the mouse vas deferens. Sensitivity to H1 and H2 receptor agonists and antagonists.
    M M Vohra and P K Rautanen
    Molecular Pharmacology November 1982, 22 (3) 602-608;
  • You have access
    Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.
    R B Clark, T J Goka, D A Green, R Barber and R W Butcher
    Molecular Pharmacology November 1982, 22 (3) 609-613;
  • You have access
    Modulation of insulin sensitivity by adenosine. Effects on glucose transport, lipid synthesis, and insulin receptors of the adipocyte.
    H G Joost and H J Steinfelder
    Molecular Pharmacology November 1982, 22 (3) 614-618;
  • You have access
    Regulation of insulin receptors in frog erythrocytes by insulin and concanavalin A. Evidence for discrete classes of insulin binding sites.
    R D Vale, A De Lean, R J Lefkowitz and J M Stadel
    Molecular Pharmacology November 1982, 22 (3) 619-626;
  • You have access
    Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine.
    M Willow and W A Catterall
    Molecular Pharmacology November 1982, 22 (3) 627-635;
  • You have access
    Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
    M A Maleque, C Souccar, J B Cohen and E X Albuquerque
    Molecular Pharmacology November 1982, 22 (3) 636-647;
  • You have access
    Etorphine binds to multiple opiate receptors of the caudate nucleus with equal affinity but with different kinetics.
    A M Tolkovsky
    Molecular Pharmacology November 1982, 22 (3) 648-656;
  • You have access
    Structural characterization of beta-endorphin through the design, synthesis, and study of model peptides.
    J W Taylor, R J Miller and E T Kaiser
    Molecular Pharmacology November 1982, 22 (3) 657-666;
  • You have access
    Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
    G Loew, G Hashimoto, L Williamson, S Burt and W Anderson
    Molecular Pharmacology November 1982, 22 (3) 667-677;
  • You have access
    Inelastic electron tunneling spectroscopic study of interaction of acetylcholine and beta-methyl acetylcholine with alumina surface.
    D Aslanian and S de Cheveigné
    Molecular Pharmacology November 1982, 22 (3) 678-686;
  • You have access
    Light-enhanced inhibition of ouabain binding to digitalis receptor in rat brain and guinea pig heart by the food dye erythrosine.
    M Hnatowich and F S LaBella
    Molecular Pharmacology November 1982, 22 (3) 687-692;
  • You have access
    Formation of ADP-sensitive phosphorylated intermediate in the electric eel Na, K-ATPase preparation.
    A Yoda and S Yoda
    Molecular Pharmacology November 1982, 22 (3) 693-699;
  • You have access
    Interaction between ouabain and the phosphorylated intermediate of Na,K-ATPase.
    A Yoda and S Yoda
    Molecular Pharmacology November 1982, 22 (3) 700-705;
  • You have access
    Mechanism of inhibition of protein synthesis by morphine in rat brain and liver.
    K C Retz and W J Steele
    Molecular Pharmacology November 1982, 22 (3) 706-714;
  • You have access
    Lack of Ca2+ ionophoretic activity of hypoglycemic sulfonylureas in excitable cells and isolated secretory granules.
    E Gylfe and B Hellman
    Molecular Pharmacology November 1982, 22 (3) 715-720;
  • You have access
    Increased fluidity of a model membrane caused by tetrahydro-beta-carbolines.
    P Peura, P Mackenzie, U Koivusaari and M Lang
    Molecular Pharmacology November 1982, 22 (3) 721-724;
  • You have access
    A theorem on de novo group contributions.
    I Lukovitz
    Molecular Pharmacology November 1982, 22 (3) 725-731;
  • You have access
    Direct detection of the sulfur trioxide radical anion during the horseradish peroxidase-hydrogen peroxide oxidation of sulfite (aqueous sulfur dioxide).
    C Mottley, T B Trice and R P Mason
    Molecular Pharmacology November 1982, 22 (3) 732-737;
  • You have access
    The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
    C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot
    Molecular Pharmacology November 1982, 22 (3) 738-744;
  • You have access
    Rat liver microsomal metabolism of propyl halides.
    H Tachizawa, T L MacDonald and R A Neal
    Molecular Pharmacology November 1982, 22 (3) 745-751;
  • You have access
    Differences in the active-site region of tumor versus normal isozymes of mammalian ATP:L-methionine S-adenosyltransferase.
    J R Sufrin and J B Lombardini
    Molecular Pharmacology November 1982, 22 (3) 752-759;
  • You have access
    Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
    D Roberts, P Franklin, G Odom, C Peck and T L Chwang
    Molecular Pharmacology November 1982, 22 (3) 760-765;
  • You have access
    Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines.
    W D Sedwick, M Hamrell, O E Brown and J Laszlo
    Molecular Pharmacology November 1982, 22 (3) 766-770;
  • You have access
    The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
    J A Houghton, A J Tice and P J Houghton
    Molecular Pharmacology November 1982, 22 (3) 771-778;
  • You have access
    Quantitation of hepatic cytochrome P1-450 mRNA with the use of a cloned DNA probe. Effects of various P-450 inducers in C57BL/6N and DBA/2N mice.
    R H Tukey, M Negishi and D W Nebert
    Molecular Pharmacology November 1982, 22 (3) 779-786;
  • You have access
    Immunochemical comparison and quantitation of microsomal flavin-containing monooxygenases in various hog, mouse, rat, rabbit, dog, and human tissues.
    G A Dannan and F P Guengerich
    Molecular Pharmacology November 1982, 22 (3) 787-794;
  • You have access
    Endocrine regulation of cadmium-sensitive cytochrome P-450 in rat liver.
    E M Lui, S R Slaughter, R M Philpot and G W Lucier
    Molecular Pharmacology November 1982, 22 (3) 795-802;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 22, Issue 3
1 Nov 1982
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics